Global Bioenergies Takeover Review Postponed to 24 November

Key highlights
  • Hearing postponed to 24 November 2025 for Global Bioenergies' takeover review.
  • New deadline for submitting offers is 12 November 2025.
  • Receivership procedure initiated on 29 September 2025.
  • Judicial liquidation may lead to delisting with shares likely having zero residual value.
Related project For subscribers
Milestones, plant data, involved companies (owners, investors, licensors, contractors) and news — kept up to date.
Global Bioenergies bio-isobutene plant, France (site undecided)
Cancelled
2023
2024-10-17

Hearing Postponement

The Commercial Court of Evry has postponed the review of takeover offers for Global Bioenergies to 24 November 2025. This decision follows a hearing held on 3 November 2025.

Offer Submission Deadline

The new deadline for submitting takeover offers is set for 12 November 2025. This extension provides potential buyers additional time to prepare their proposals.

Receivership and Sale Process

Global Bioenergies initiated a pre-pack sale process on 3 June 2025, and the Evry Commercial Court opened a receivership procedure on 29 September 2025 to facilitate a sale plan.

Potential Outcomes

If certain assets or activities are acquired, or if no final offer is made, judicial liquidation proceedings will commence. This could result in the delisting of Global Bioenergies' shares, with their residual value likely being zero due to liabilities exceeding asset sale proceeds.

Financial Statement Delays

The company is unable to finalize its half-year financial statements due to the uncertainty surrounding the ongoing takeover process.

Source: Global Bioenergies

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

29 September 2025
Global Bioenergies Enters Receivership

Receivership aims to continue operations and preserve jobs. Four asset offers are pending. Without a final offer, liquidation and delisting will follow. Hearing set for 03 November 2025.